Capital Network's Ed Stacey discusses InnovaDerma (LON:IDP) following the release of their results for the year to the end of June 2018.
These were in line with market expectations, with 21% like-for-like revenue growth.
InnovaDerma specialises in the development, manufacture and marketing of clinically proven products in life sciences, beauty, and personal care.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of InnovaDerma PLC named herein, including the promotion by the Company of InnovaDerma PLC in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HERE